Supplementary Table S1 from Tumoral and Systemic Immune Correlates of Response to Concurrent Pembrolizumab and Chemoradiotherapy in Patients with Resected High-Risk Head and Neck Squamous Cell Carcinoma
Authors:
- Lazar VujanovicLVLazar Vujanovic
- Pedro Torres-SaavedraPTPedro Torres-Saavedra
- Fei TuFTFei Tu
- Ravindra UppaluriRURavindra Uppaluri
- Min YaoMYMin Yao
- Josephine ChenJCJosephine Chen
- Richard JordanRJRichard Jordan
- Jessica L. GeigerJGJessica L. Geiger
- Srinivas JujjavarapuSJSrinivas Jujjavarapu
- Arnab ChakravartiACArnab Chakravarti
- Minh PhanMPMinh Phan
- Farzan SiddiquiFSFarzan Siddiqui
Open Access
- 15 September 2026
- other
- Published by American Association for Cancer Research (AACR)